ATOSSA THERAPEUTICS, INC. — Director's Dealing 2017

May 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2017-05-24

Reporting Person: WEAVER GREGORY L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-24	Stock Option (right to buy)	$0.47	A	54949	Acquired	2027-05-24	Common Stock (54949)	Direct

Footnotes

F1: The options shall vest on a quarterly basis over the next 12 months.